TITLE

Azithromycin in the management of Chlamydia trachomatis infections

AUTHOR(S)
Ridgway, G. L.
PUB. DATE
January 1996
SOURCE
International Journal of STD & AIDS;Jan1996 Supplement 1, Vol. 7, p5
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The unique pharmacological profile of the azalide macrolide azithromycin, coupled with its in vitro activity against both Chlamydia trachomatis and the ureaplasmas, suggested that genital infections caused by these bacteria could be successfully treated with a single dose of the antibiotic. This has now been confirmed in worldwide clinical studies. A single oral dose of azithromycin 1 g eradicates C. trachomatis in almost 100% of cases of non-gonococcal urethritis and cervicitis. Unfortunately, there are no specific clinical signs for genital chlamydial infection. It is therefore necessary to use therapy effective against known and unknown pathogens for treating lower genital tract infection. Clinical cure rates for both chlamydial and non-chlamydial, non-gonococcal infections compare favourably with standard 7-day doxycycline therapy, being in excess of 85%. Side-effects are few (<20%) and essentially minor.
ACCESSION #
22201774

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics